Results

1–2 of 2 results for treatment variation

Evaluating the Visual, Anatomic, and Treatment Effects of Switching from Higher-cost Anti-VEGF to Lower-cost Bevacizumab After Loss of Copay Assistance (Good Days) Funding in Neovascular Age-Related Macular Degeneration
Jesse J Jung, MD, FASRS
Updates from the Field
2026
Real-World Trends in Surgical Care for Retinal Detachment Repair Among Vitreoretinal Surgeons in the United States
Avni P Finn, MD, MBA, FASRS
Annual Meeting Talks
2021